Effects of a Test Food for Bone Metabolism Marker - Effects of a Test Food for Bone Metabolism Marker

MORINAGA & CO., LTD.0 sites24 target enrollmentAugust 3, 2018

Conditions/A(healthy adults)

Overview

Phase: 未知
Intervention: Not specified
Conditions: /A(healthy adults)
Sponsor: MORINAGA & CO., LTD.
Enrollment: 24
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

August 3, 2018

End Date

December 30, 2018

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

MORINAGA & CO., LTD.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\)Individuals using medical products and are judged that treatment is necessaryby examination doctor. 2\)Individuals who have advanced anemia. 3\)Individuals who have possibility of allergy symptoms onset by the test food and who cause severe allergic symptoms in foods and medicines, persons with fear of oral allergy syndrome and latex fruit syndrome. (In particular, gelatin, peach, pork, banana, melon, avocado, pineapple, papaya, mango, peach, kiwi, chestnut, tomato, cashew nut, pistachio) 4\)Individuals who have an addiction to alcohol or a mental illness. 5\)Individuals who have a habit of smoking. 6\)Individuals whose life style will change during the test period. 7\)Individuals with probable seasonal allergy, such as pollinosis, during the test period.(In particular, Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense) 8\)Individuals who will ingest health\-promoting foods, foods for specified health uses, health foods, or supplements during the test period. 9\)Individuals who conducted hormone replacement therapy in the past 6 months. 10\)Individuals who have suffered bone injuries or illnesses such as fractures in the past 6 months. 11\)Individuals who were hospitalized and received treatment in the past 6 months. 12\)Individuals who participated in other clinical studies in the past 3 months. 13\)Individuals judged inappropriate for the study by the principal.